Mode
Text Size
Log in / Sign up

Iron Deficiency Anemia

Part of Anemia

9 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Iron Deficiency Anemia

42 trials tracked for Iron Deficiency Anemia: 31 in phase 3 or 4 and 13 with published results. The most-cited published study has 297 citations.

42Trials tracked
31Phase 3 & 4
0Recruiting
13With published results
Phase distribution
Phase 4 8 Phase 3 23 Phase 2 4 Phase 1 1 Other / NA 6
  1. Phase 3 Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Completed · 297 cited
  2. Phase 3 Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Completed · 295 cited
  3. Phase 3 A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA) Completed · 199 cited
  4. Phase 4 Comparison of NovaFerrum® vs Ferrous Sulfate Treatment in Young Children With Nutritional Iron Deficiency Anemia Completed · 142 cited
  5. Phase 3 Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA) Completed · 107 cited
  6. Phase 3 Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease Completed · 102 cited
Show 36 more trials
  1. Phase 3 A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia Completed · 79 cited
  2. Phase 3 A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia Completed · 77 cited
  3. Phase 3 Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease Completed · 38 cited
  4. Phase 4 Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia Completed · 13 cited
  5. Phase 3 Daily vs. Every Other Day Oral Iron Supplementation in Patients With Absolute Iron Deficiency Anemia Completed · 9 cited
  6. Phase 3 A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia Completed · 9 cited
  7. Phase 3 Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia Completed · 2 cited
  8. Phase 4 KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial) Completed
  9. Phase 4 Alternate Day Versus Daily Oral Iron Therapy in Adolescents Completed
  10. Phase 4 Iron Indices and Intravenous Ferumoxytol: Time to Steady State Completed
  11. Phase 4 Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Completed
  12. Phase 4 Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents Completed
  13. Phase 4 Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure Completed
  14. Phase 3 Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD Completed
  15. Phase 3 An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®) Completed
  16. Phase 3 To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia Completed
  17. Phase 3 Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044 Completed
  18. Phase 3 Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA Completed
  19. Phase 3 Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD) Completed
  20. Phase 3 Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease Completed
  21. Phase 3 Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA) Completed
  22. Phase 3 Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia Completed
  23. Phase 3 A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized Trial to Evaluate Efficacy & Safety in Anemia Subjects Completed
  24. Phase 3 Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function Completed
  25. Phase 3 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients. Completed
  26. Phase 2 Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA) Completed
  27. Phase 2 Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis Completed
  28. Phase 2 Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women Completed
  29. Phase 2 Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding Completed
  30. Phase 1 Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers Completed
  31. N/A Universal Screening for Tuberculosis and Anemia With the CHICA System Completed
  32. N/A Feraccru® Real World Effectiveness Study in Hospital Practice ( FRESH ) Completed
  33. N/A Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis Completed
  34. N/A Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia Completed
  35. N/A Trial Comparing Iron Supplementation Versus Routine Iron Intake in Very Low Birth Weight Infants Completed
  36. N/A Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study Completed

Showing the 42 most-cited and recently-updated of 42 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Iron Deficiency Anemia: what the trials found

Several iron-based interventions demonstrated significant improvements in hemoglobin (Hb) levels for patients with anemia. Elemental iron showed a statistically significant increase in Hb concentration over time 1. Ferumoxytol was associated with significant increases in Hb concentrations at various time points [14, 15, 17] and showed a median Hb increase of 11.45 units post-intervention 20. Additionally, ferric maltol demonstrated a statistically significant increase in Hb concentration from baseline to week 16 16.

Iron isomaltoside/ferric derisomaltose was associated with significant increases in Hb concentrations at several intervals (weeks 1, 2, 4, and 8) [12, 13]. However, this intervention showed a significantly higher incidence of hypophosphatemia compared to the comparator group across multiple studies [9, 10]. Ferric carboxymaltose resulted in significant increases in both ferritin levels and transferrin saturation (TSAT) from baseline to day 35 22, although the change in Hb concentration was not statistically significant 22.

Other iron preparations showed varying results. Ferrous sulfate was evaluated for changes in ferritin, serum iron, and TSAT at 12 weeks 18. Ferric citrate did not show a statistically significant difference in the composite endpoint of initiation of maintenance dialysis or all-cause mortality 19.

For the clinician treating this condition

  • Ferumoxytol is associated with significant increases in hemoglobin levels and improved fatigue scores in patients with anemia [14, 15, 17].
  • Iron isomaltoside/ferric derisomaltose effectively increases hemoglobin concentration but is associated with a significantly higher risk of hypophosphatemia compared to other treatments [9, 10, 12, 13].
  • Ferric carboxymaltose demonstrates significant improvements in ferritin and TSAT levels 22.

AI synthesis of 6 cited trials, updated Jun 24, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Anemia

Related studies from across the Anemia family.

CHIP prevalence is 8.5% in adults and associated with higher systemic immune-inflammation index
Genetics & Precision Medicine Meta-analysis
CHIP prevalence is 8.5% in adults and associated with higher systemic immune-inflammation index Large study links blood mutations to heart and lung risks
This meta-analysis of a multi-ancestry cohort of 59,598 adults identifies a 8.5% prevalence of clonal hematopoiesis of indeterminate potenti…
A large study of over 59,000 people found that specific blood mutations, known as CHIP, are linked to heart, lung, and blood cancer risks.
Sickle cell trait is associated with increased risk of kidney disease, pulmonary embolism, and anemia
Hematology Meta-analysis
Sickle cell trait is associated with increased risk of kidney disease, pulmonary embolism, and anemia Sickle cell trait linked to higher risks of kidney and blood issues
This meta-analysis analyzed 4,813 individuals with sickle cell trait (SCT) to identify phenome-wide and laboratory-wide associations. The st…
New data shows that people with sickle cell trait may face higher risks for kidney disease, anemia, and other serious health conditions.
Preoperative anaemia increases risk of red cell transfusion and acute kidney injury in cardiac surgery
Cardiology Meta-analysis
Preoperative anaemia increases risk of red cell transfusion and acute kidney injury in cardiac surgery Preoperative Anaemia Linked to Higher Risks During Cardiac Surgery
This meta-analysis of observational cohort studies involving 74,571 adults undergoing cardiac surgery found that preoperative anaemia is ass…
Patients with anemia before heart surgery may face higher risks of kidney issues, infections, and the need for blood transfusions.
Heart Failure Evidence in Somalia Is Fragmented and Insufficient to Estimate National Burden
Cardiology Meta-analysis
Heart Failure Evidence in Somalia Is Fragmented and Insufficient to Estimate National Burden Review Identifies Common Causes of Heart Failure in Somalia
This scoping review synthesizes 12 studies on heart failure in Somalia, finding that evidence is geographically concentrated, methodological…
A review of 12 studies identifies key conditions like hypertension and heart disease that contribute to heart failure in the Somali region.
Integrated Intervention Improves Weight and Reduces Anemia in Term SGA Infants
Pediatrics RCT
Integrated Intervention Improves Weight and Reduces Anemia in Term SGA Infants Integrated care package improves growth in small-for-gestational-age infants
This randomized trial in 1300 term small-for-gestational-age infants in South Delhi found that an integrated health, nutrition, stimulation,…
A combined program of nutrition, health, and early stimulation helped small-for-gestational-age infants achieve better weight and growth out…
Isolated gastric Kaposi sarcoma occurs following allogeneic hematopoietic stem cell transplantation in rare cases
Rheumatology Sys. Review
Isolated gastric Kaposi sarcoma occurs following allogeneic hematopoietic stem cell transplantation in rare cases Rare Gastric Kaposi Sarcoma Found After Stem Cell Transplant
This case report and literature review identifies 20 cases of Kaposi sarcoma following allogeneic hematopoietic stem cell transplantation. T…
A rare case of stomach cancer linked to stem cell transplants highlights the need for early testing when patients have new digestive symptom…
Pegylated erythropoietin provides improved Hb stability and reduced dosing frequency in CKD-related anemia
Infectious Disease Guideline
Pegylated erythropoietin provides improved Hb stability and reduced dosing frequency in CKD-related anemia Expert Consensus Shows Pegylated Erythropoietin Benefits Chronic Kidney Disease Patients
This expert consensus evaluates the use of pegylated erythropoietin for CKD-related anemia in India. The consensus indicates that pegylated …
A new expert consensus suggests that pegylated erythropoietin can improve hemoglobin stability and reduce dosing frequency for patients with…
Traditional Tibetan feeding practices are linked to high anemia rates and possible necrotizing enterocolitis
Primary Care & Family Medicine Sys. Review
Traditional Tibetan feeding practices are linked to high anemia rates and possible necrotizing enterocolitis Traditional feeding practices impact health of infants in high altitudes
This systematic review synthesizes evidence regarding traditional feeding practices among Tibetan infants aged 0-24 months in high-altitude …
Early introduction of solid foods and low breastfeeding rates are linked to anemia and other risks for infants living in the Tibetan highlan…
HIV co-infection triples MDR-TB mortality risk; low BMI and anaemia also raise risk
Infectious Disease Meta-analysis
HIV co-infection triples MDR-TB mortality risk; low BMI and anaemia also raise risk HIV and other risk factors linked to multidrug-resistant tuberculosis deaths
This meta-analysis of 36,693 patients with multidrug-resistant tuberculosis (MDR-TB) found that HIV co-infection, lower educational attainme…
Patients with multidrug-resistant tuberculosis face higher risks of death if they also have HIV, low body mass index, or certain other healt…
Allogeneic hematopoietic stem cell transplantation achieves transfusion independence in children with KLF1 mutation-associated CDA IV
Pediatrics Sys. Review
Allogeneic hematopoietic stem cell transplantation achieves transfusion independence in children with KLF1 mutation-associated CDA IV Stem Cell Transplant Shows Promise for Rare Blood Disorder
This case report and literature review examines allogeneic hematopoietic stem cell transplantation (HSCT) for pediatric patients with KLF1 m…
A small study shows that stem cell transplants may help children with a rare, severe form of anemia become independent from blood transfusio…
Prebiotics, probiotics, and synbiotics do not provide clinically important benefits on hemoglobin or ferritin in children
Pediatrics Meta-analysis
Prebiotics, probiotics, and synbiotics do not provide clinically important benefits on hemoglobin or ferritin in children Review of Probiotics and Prebiotics for Treating Anemia in Children
This meta-analysis of 4188 children found that prebiotics, probiotics, and synbiotics (alone or with iron) did not produce significant effec…
New research looks at whether healthy bacteria can help children with low blood iron. Results show these supplements do not significantly im…
Maternal anaemia research surges 9-fold from 2000 to 2024, but gaps persist in low-income regions
Psychiatry Guideline
Maternal anaemia research surges 9-fold from 2000 to 2024, but gaps persist in low-income regions Mapping the Growth and Trends of Research on Maternal Anaemia Over Time
A bibliometric analysis of 1,007 articles on maternal anaemia (2000-2024) shows exponential publication growth (R2=0.9054). Most research or…
A massive review of over 1,000 articles shows how research on anemia in pregnant women has grown rapidly since 2000.